Studies have indicated that HDAC5 participated in cancer progression through various oncogenetic signaling pathways, such as TAp63/maspin (21), HIPK2/HIF1α (70), and p65/NF-κB pathways (95)(Figure 4). This evidence concerns the gene HDAC5 and cancer.